<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Neuroprotective effect of <z:chebi fb="0" ids="6497">lipoxin</z:chebi> A(4) <z:chebi fb="36" ids="29309">methyl</z:chebi> <z:chebi fb="21" ids="35701">ester</z:chebi> (LXA(4) ME) was tested in a rat model of permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>LXA(4) ME was administrated through intracerebroventricular injection immediately after middle cerebral artery was occluded </plain></SENT>
<SENT sid="2" pm="."><plain>Administration of LXA(4) ME ameliorated neurological deficit, reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, attenuated histological damage, and decreased number of apoptotic neuron induced by ischemic insult </plain></SENT>
<SENT sid="3" pm="."><plain>These neuroprotective effects of LXA(4) ME were associated with inhibition of neutrophil infiltration, <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation, and astrocyte activation </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, LXA(4) ME also attenuated proinflammatory cytokines (TNF-alpha and IL-1beta) production </plain></SENT>
<SENT sid="5" pm="."><plain>These data suggest that LXA(4) ME protects neuron against permanent <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> by inhibiting <z:mp ids='MP_0001845'>inflammatory responses</z:mp> </plain></SENT>
</text></document>